URGENT PANDEMIC INFORMATION

In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List


Next Generation Kinase Inhibitors Summit


Date
Mar 29, 2022 - 01:00 PM - Mar 31, 04:45 PM
Organizer
Hanson Wade
Venue
BOSTON PARK PLAZA
Location
50, Park Plz

Boston,
MA,
USA,
ZIP: 02116
Phone: + 1 415 735 3289

Ticket Price: USD 2599.00 to USD 4348.00


Celebrating 20 years of FDA approval and high efficacy profiles, kinase inhibitors have changed the face of oncology treatment. However, increasing resistance and safety issues limit the success of existing kinase inhibitor classes.

The inaugural Next Generation Kinase Inhibitors Summit is the only industry-focused meeting dedicated to applying novel kinase biology to drug development and innovating existing programs to produce the next wave of kinase inhibitor drugs which are able to show efficacious and durable clinical response in oncology and beyond.

Boasting 20+ speakers, 1 deep-dive workshop and over 3 days of unrivalled content spanning discovery, R and D and clinical development, this event is a unique opportunity for your team to identify and target the undruggable, elevate drug design for improved target selectivity, overcome the blood brain barrier and rationalize combinations for more durable responses.

Collaborate with 80+ senior drug developers in March to achieve the next generation of these kinase inhibitor therapies with optimized specificity, maximal durability to deliver the best clinical outcomes.

URLs:
Brochure: https://go.evvnt.com/944626-0?pid=1052
Tickets: https://go.evvnt.com/944626-1?pid=1052

Prices:
Industry Pricing - Conference Only: USD 2999.00,
Industry Pricing - Conference + 1 Workshop : USD 3648.00,
Academic pricing - Conference Only : USD 2599.00,
Academic pricing - Conference + 1 Workshop: USD 3148.00,
Service Provider Pricing - Conference Only : USD 3599.00,
Service Provider Pricing - Conference + 1 Workshop: USD 4348.00


Speaker Details


Leslie Cousens, Senior Director, Search and Evaluation, Respiratory and Immunology, AstraZeneca, Markus Queisser, Scientific Director, GlaxoSmithKline, Tony Hunter, Professor, Salk Institute, Jan S. Rosenbaum, Ph.D, CEO and CSO, Kurome Therapeutics, Lewis Cantley, Professor of Cancer Biology, Cornell University, Steve Fruchtman, President and CEO, Onconova Therapeutics, Harish Dave, CMO, AUM Biosciences, Matt Lucas, SVP, Drug Discovery, Black Diamond, Milton Werner, Founder, President and CEO, Inhibikase Therapeutics, David Witter, VP, Preclinical Research, Cullinan Oncology, Mehdi Rashighi, Founding Director, Connective Tissue Disease Clinic and Research Center, UMass Chan Medical School, Michelle Sidor, Director of Biology, DeepCure, George Poulogiannis, Team Leader, Signalling and Cancer Metabolism Group, Institute of Cancer Research, Gerhard Mueller, CSO, Anavo Therapeutics, Paul Barclay, VP, Global Program Head, LEO Pharma, Emmanuel Normant, VP, Preclinical Sciences, TG Therapeutics, Sandra Wiley, Senior Medical Scientist, MEI Pharma, Brian Hopkins, Director R and D, Biogen, Matthew Wongchenko, Principal Scientific Manager, Genentech

Event Categories
Keywords: conference




Comments








Events Calendar

SunMonTueWedThuFriSat
27 28 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31 1 2

Event Location

Newsletters

VIP Life Time Subscription to our Newsletters!
$399.99
$299.99